Cases of typhoid fever-imported into England, Scotland and Wales (2000-2003)

被引:49
作者
Cooke, Fiona J.
Day, Martin
Wain, John
Ward, Linda R.
Threlfall, E. John
机构
[1] Hlth Protect Agcy, Ctr Infect, London NW9 5HT, England
[2] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
typhoid fever; Salmonella Typhi; bacterial infections; antibiotic resistance; epidemiology; travel medicine;
D O I
10.1016/j.trstmh.2006.07.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Although typhoid fever is no longer endemic in most of the developed world, it remains a major infectious disease in less developed regions and imported cases continue to occur in returning travellers, immigrants or migrant workers. We analysed all 692 isolates of Salmonella enterica subspecies enterica serovar Typhi from cases in England, Scotland and Wales that were sent to the Laboratory of Enteric Pathogens at the Health Protection Agency, Centre for Infections, London, UK between 2000 and 2003. The country of acquisition was known for 416 isolates (60%), and the majority of these (70%) came from India or Pakistan. Overall, 24 countries were listed, mainly in Asia and Africa. A total of 48 phage types were detected, 41% of which were Vi-phage type E1. Antimicrobial susceptibility testing revealed that 22% of isolates were multidrug resistant (MDR) (defined as resistance to chloramphenicol, ampicillin and co-trimoxazole) and 39% were quinolone resistant. A significant number of isolates (n = 49) were sensitive to nalidixic acid by disk test but exhibited low-level ciprofloxacin resistance, suggesting a novel mechanism of resistance and reinforcing the need for minimum inhibitory concentration determination. Overall, 13% of. isolates were both MDR and likely to show a poor response to a fluoroquinolone. A third-generation cephalosporin (e.g. ceftriaxone) should be considered as empirical therapy in regions of the Indian subcontinent where resistance is now at high levels as well as in patients returning from these areas. This study helps to describe the epidemiology of antimicrobial drug resistance in typhoid fever. (C) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:398 / 404
页数:7
相关论文
共 37 条
  • [1] Is it time to change fluoroquinolone breakpoints for Salmonella spp.?
    Aarestrup, FM
    Wiuff, C
    Molbak, K
    Threlfall, EJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 827 - 829
  • [2] Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States -: Antimicrobial resistance on the rise
    Ackers, ML
    Puhr, ND
    Tauxe, RV
    Mintz, ED
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20): : 2668 - 2673
  • [3] Health disparities among travelers visiting friends and relatives abroad
    Angell, SY
    Cetron, MS
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (01) : 67 - 72
  • [4] [Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1
  • [5] Detection of Vi-negative Salmonella enterica serovar Typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan
    Baker, S
    Sarwar, Y
    Aziz, H
    Haque, A
    Ali, A
    Dougan, G
    Wain, J
    Haque, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4418 - 4425
  • [6] Typhoid and paratyphoid fever in travellers
    Connor, BA
    Schwartz, E
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (10) : 623 - 628
  • [7] Cooke F., 2005, SALMONELLA INFECT CL, P25
  • [8] Cooke Fiona J, 2004, Travel Med Infect Dis, V2, P67, DOI 10.1016/j.tmaid.2004.04.005
  • [9] Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
  • [10] Ekdahl K, 2005, J TRAVEL MED, V12, P197, DOI 10.2310/7060.2005.12405